IADR Abstract Archives

Clinical Evaluation of Sensitivity Using 22% Carbamide Peroxide Gel

Objectives: To clinically evaluate the sensitivity of commercially available 22% carbamide peroxide with 3% potassium nitrate, at home bleaching system.

Methods: a total of 21 subjects with no history of previous tooth whitening and no tooth sensitivity were recruited for at-home whitening clinical study using Venus White 22% carbamide peroxide (Heraeus Kulzer).  Subjects were treated nightly for 2 weeks with a maxillary custom tray.   Sensitivity rating from 0-10 with zero representing no pain and 10 representing worst possible pain was documented at the initial appointment.   Subjects were asked to document their sensitivity every morning for 14 days during treatment, and 14 days post bleaching.  Wilcoxon matched-paired signed-rank test and Bonferroni correction for multiple comparisons were used at the 0.05 level of significance.

Results:  Mean, standard deviation, and median sensitivity scores are as follows:

 

 

Average week 1 sensitivity

Average week 2 sensitivity

Average week 3 sensitivity

Average week 4 sensitivity

Mean (SD)

1.2(1.2)

1.7(2.0)

0.2(0.4)

0.1(0.3)

Median

0.78

0.78

0

0

25%, 75% quantile

0.07, 2.14

0.07, 2.57

0, 0.07

0, 0

 

There was no statistically significant difference between week 1 and week 2 (p=0.17), or week 3 and week 4 (p=0.19). There was a statistically significant difference, between week 1 and week 3, week 1 and week 4, week 2 and week 3, week 2 and week 4; p<0.01, respectively.

Conclusions: Patients receiving nightly treatment with a commercially available 22% carbaminde peroxide 3% potassium nitrate, at-home bleaching agent reported low sensitivity levels with a mean value of below 2 on a 0-10 scale.  Supported by Heraeus Kulzer

 


Division: IADR/AADR/CADR General Session
Meeting: 2011 IADR/AADR/CADR General Session (San Diego, California)
Location: San Diego, California
Year: 2011
Final Presentation ID: 556
Abstract Category|Abstract Category(s): Dental Materials 4: Clinical Trials
Authors
  • S Eldiwany, Magda  ( University of Texas at Houston, Houston, TX, USA )
  • Ontiveros, Joe C.  ( University of Texas at Houston, Houston, TX, USA )
  • Paravina, Rade D.  ( University of Texas - Houston/Health Science Center, Houston, TX, USA )
  • Eldiwany, Michelle  ( University of Texas - Houston/Health Science Center, Houston, TX, USA )
  • Wang, Weiwei  ( University of Texas - Houston/Health Science Center, Houston, TX, USA )
  • SESSION INFORMATION
    Poster Session
    Clinical Studies
    03/17/2011